IPERIONX Ramps US Titanium Production, Targets 10,000 TPA by 2030

TL;DR

**IPERIONX is a speculative buy, betting on its patented tech to disrupt the titanium market and secure a vital U.S. supply chain.**

AI Summary

IPERIONX Ltd (IPX) is transitioning to a commercial producer of titanium metal products in the United States, leveraging patented technologies for lower energy, cost, and carbon emissions. The company has completed commissioning of initial commercial operations at its Titanium Manufacturing Campus in Virginia, achieving a production rate of 125 metric tons per year. IPX plans a significant scale-up to 1,400 metric tons per year by 2027, with an ambitious long-term goal of over 10,000 tpa by 2030, aiming for cost competitiveness with stainless steel and aluminum. The company's proprietary technologies, including HAMR™ and HSPT™, are central to its strategy of re-shoring a sustainable U.S. titanium supply chain, as the U.S. currently produces no primary titanium metal. As of December 31, 2024, the aggregate market value of non-affiliate shares was approximately $1.08 billion, based on an A$5.50 closing price on Nasdaq. The company is not yet a well-known seasoned issuer and prepares its financial statements using International Financial Reporting Standards (IFRS).

Why It Matters

IPERIONX's efforts to re-shore titanium production are critical for U.S. national security and industrial independence, given that China and Russia control approximately 75% of global primary titanium supply. For investors, this represents a high-growth opportunity in a strategic materials sector, potentially disrupting traditional, high-cost Kroll process methods with more sustainable and efficient technologies. Employees and customers stand to benefit from a localized, resilient supply chain for high-performance titanium alloys. The broader market could see increased competition and innovation in advanced manufacturing, potentially lowering costs for industries like aerospace and defense that rely heavily on titanium.

Risk Assessment

Risk Level: high — The company explicitly states 'risks related to our limited operating history in the titanium metal manufacturing industry' and 'risks related to our ability to commercialize our titanium technologies' in its forward-looking statements. While initial commercial operations are at 125 metric tons per year, the planned scale-up to 1,400 metric tons by 2027 and over 10,000 tpa by 2030 represents a significant, unproven expansion that carries substantial execution risk.

Analyst Insight

Investors should closely monitor IPERIONX's progress on its stated production scale-up targets, particularly the 1,400 metric tons per year by 2027. Any delays or cost overruns in achieving these milestones would be a significant red flag, while successful execution could signal strong upside potential.

Key Numbers

• $1.08 billion — Aggregate market value of non-affiliate shares (As of December 31, 2024, based on A$5.50 closing price)
• 125 metric tons per year — Initial commercial titanium production rate (Achieved at Titanium Manufacturing Campus in Virginia)
• 1,400 metric tons per year — Planned titanium production rate (Targeted for 2027 scale-up)
• 10,000 tpa — Long-term titanium production goal (Targeted by 2030 for high-performance components)
• 75% — Global primary titanium supply controlled by China and Russia (Highlights U.S. reliance and IPERIONX's strategic importance)
• 319,927,854 — Ordinary shares outstanding (As of June 30, 2025)
• A$5.50 — Closing market price per share (On December 31, 2024, on the Nasdaq Capital Market)

Key Players & Entities

• IPERIONX Limited (company) — Registrant and titanium metal producer
• Anastasios Arima (person) — Chief Executive Officer and Managing Director of IPERIONX
• United States (regulator) — Country where IPERIONX is re-shoring titanium supply chain
• China (company) — Controls approximately 75% of global primary titanium supply
• Russia (company) — Controls approximately 75% of global primary titanium supply
• Nasdaq Capital Market (regulator) — Exchange where IPERIONX ADSs are registered
• Securities and Exchange Commission (regulator) — U.S. regulatory body for filings
• Titanium Manufacturing Campus (company) — IPERIONX's commercial operations facility in Virginia
• HAMR™ (company) — IPERIONX's patented hydrogen assisted metallothermic reduction technology
• HSPT™ (company) — IPERIONX's patented hydrogen sintering and phase transformation process technology

FAQ

Risk Factors

• Dependence on Key Personnel [high — operational]: The success of IperionX is significantly dependent on the continued service of its key management personnel, particularly its CEO and CTO. The loss of their expertise could materially and adversely affect the Company's ability to execute its business plan and achieve its strategic objectives.
• Competition and Market Acceptance [high — market]: The Company faces competition from established global titanium producers and alternative materials. Failure to achieve cost competitiveness with stainless steel and aluminum, or to gain market acceptance for its products, could hinder revenue growth and profitability.
• Environmental Regulations [medium — regulatory]: The Company's operations are subject to stringent environmental laws and regulations in the United States, including the Clean Air Act (CAA) and Clean Water Act (CWA). Non-compliance or changes in these regulations could result in significant fines, operational disruptions, and reputational damage.
• Future Funding Requirements [high — financial]: The Company's ambitious scale-up plans require substantial capital investment. There is no guarantee that IperionX will be able to secure the necessary future funding through equity, debt, or other means, which could impede its growth trajectory.
• Reliance on Proprietary Technology [high — operational]: IperionX's business model relies heavily on its patented HAMR™ and HSPT™ technologies. Any failure to protect its intellectual property, or challenges to the efficacy or scalability of these technologies, could have a material adverse effect on the business.
• Supply Chain and Geopolitical Risks [medium — market]: The global primary titanium supply is concentrated, with 75% controlled by China and Russia. Disruptions to this supply chain due to geopolitical events or trade restrictions could impact raw material availability and pricing, although IPX aims to mitigate this by re-shoring U.S. production.

Industry Context

The global titanium market is characterized by high production costs and significant reliance on a few key suppliers, notably China and Russia, which control approximately 75% of the primary supply. This creates a strategic vulnerability for countries like the U.S., which currently produces no primary titanium metal. IperionX aims to disrupt this landscape by establishing a domestic, sustainable, and cost-competitive supply chain using advanced, lower-energy proprietary technologies.

Regulatory Implications

IperionX's operations are subject to U.S. environmental regulations such as the Clean Air Act and Clean Water Act. Compliance is critical to avoid penalties and operational disruptions. Furthermore, the company's focus on re-shoring critical materials like titanium may align with U.S. government initiatives like the Defense Production Act, potentially offering avenues for support but also increasing scrutiny.

What Investors Should Do

1. Monitor production ramp-up progress against stated targets (1,400 tpa by 2027, 10,000+ tpa by 2030).
2. Evaluate the company's ability to secure future capital for expansion.
3. Assess market adoption and pricing power relative to established materials like stainless steel and aluminum.
4. Track any developments related to U.S. government support or strategic initiatives for domestic critical material production.

Key Dates

• 2024-12-31: Aggregate market value of non-affiliate shares reached $1.08 billion — Indicates significant market valuation and investor confidence at the end of the reporting period.
• 2025-06-30: 319,927,854 ordinary shares outstanding — Provides a baseline for calculating per-share metrics and understanding the company's capital structure.

Glossary

HAMR™

IperionX patented technology for hydrogen assisted metallothermic reduction. (This is a core proprietary technology enabling the company's low-energy, low-cost titanium production.)

HSPT™

IperionX patented technology for hydrogen sintering and phase transformation process. (Another key proprietary technology contributing to the company's unique manufacturing process.)

IFRS

International Financial Reporting Standards. (The accounting framework used by IperionX for its financial statements, important for understanding financial reporting differences.)

DPA Title III

A provision of the Defense Production Act of 1950 that allows the President to expand the production and supply of critical materials necessary for national defense. (Highlights potential government support and strategic importance of titanium production for U.S. national security.)

CO2e

Carbon dioxide equivalents. (Used to measure the greenhouse gas emissions associated with the company's production processes, emphasizing its low-carbon claims.)

tpa

Tons per annum (metric tons per year). (Standard unit for measuring production capacity and output in the metals industry.)

Year-Over-Year Comparison

The provided text is from a 20-F filing and does not contain comparative data from a previous filing. Therefore, a direct comparison of revenue growth, margin changes, or new risks versus the prior year cannot be made based solely on this information.

Key Financial Figures

• $1.08 billion — second fiscal quarter was approximately $1.08 billion (assuming that the registrant's only af
• $5.50 — e closing market price on that date of A$5.50 per share as reported on the Nasdaq Cap
• $35.3 million — near future. We incurred net losses of $35.3 million and $21.8 million for fiscal 2025 and f
• $21.8 million — ncurred net losses of $35.3 million and $21.8 million for fiscal 2025 and fiscal 2024, respec
• $46.1 million — m operating and investing activities of $46.1 million and $25.1 million for fiscal 2025 and f
• $25.1 million — vesting activities of $46.1 million and $25.1 million for fiscal 2025 and fiscal 2024, respec
• $54.8 million — June 30, 2025, we had cash reserves of $54.8 million and net assets of $92.4 million. In th
• $92.4 million — rves of $54.8 million and net assets of $92.4 million. In the longer term, the successful sc

Filing Documents

• ipx-20250630.htm (20-F) — 3306KB
• ex81-subsidiaries.htm (EX-8.1) — 6KB
• ipx-20250630xex121.htm (EX-12.1) — 11KB
• ipx-20250630xex122.htm (EX-12.2) — 11KB
• ipx-20250630xex131.htm (EX-13.1) — 5KB
• ipx-20250630xex132.htm (EX-13.2) — 5KB
• ex152-auditorconsent.htm (EX-15.2) — 3KB
• ex153-qpconsent.htm (EX-15.3) — 5KB
• ipx-20250630_g1.jpg (GRAPHIC) — 5KB
• ipx-20250630_g10.jpg (GRAPHIC) — 219KB
• ipx-20250630_g11.jpg (GRAPHIC) — 1373KB
• ipx-20250630_g2.jpg (GRAPHIC) — 168KB
• ipx-20250630_g3.jpg (GRAPHIC) — 557KB
• ipx-20250630_g4.jpg (GRAPHIC) — 258KB
• ipx-20250630_g5.jpg (GRAPHIC) — 39KB
• ipx-20250630_g6.jpg (GRAPHIC) — 166KB
• ipx-20250630_g7.jpg (GRAPHIC) — 46KB
• ipx-20250630_g8.jpg (GRAPHIC) — 20KB
• ipx-20250630_g9.jpg (GRAPHIC) — 633KB
• 0001898601-25-000013.txt ( ) — 21999KB
• ipx-20250630.xsd (EX-101.SCH) — 108KB
• ipx-20250630_cal.xml (EX-101.CAL) — 91KB
• ipx-20250630_def.xml (EX-101.DEF) — 367KB
• ipx-20250630_lab.xml (EX-101.LAB) — 857KB
• ipx-20250630_pre.xml (EX-101.PRE) — 613KB
• ipx-20250630_htm.xml (XML) — 2558KB

Risk Factors

Risk Factors 11 ITEM 4 INFORMATION ON THE COMPANY 26 A. History and Development of the Company 26 B. Business Overview 26 C. Organizational Structure 47 D. Property, Plant and Equipment 48 ITEM 4A. UNRESOLVED STAFF COMMENTS 56 ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS 56 A. Operating Results 57 B. Liquidity and Capital Resources 58 C. Research and Development, Patents and Licenses 61 D. Trend Information 61 E. Critical Accounting Policies and Estimates 61 ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES 61 A. Directors and Senior Management 61 B. Compensation 64 C. Board Practices 77 D. Employees 79 E. Share Ownership 79 ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS 79 A. Major Shareholders 79 B. Related Party Transactions 81 C. Interests of Experts and Counsel 81 ITEM 8. FINANCIAL INFORMATION 82 A. Consolidated Statements and Other Financial Information 82 B. Significant Changes 82 ITEM 9. THE OFFER AND LISTING 82 A. Offer and Listing Details 82 B. Plan of Distribution 82 C. Markets 82 D. Selling Shareholders 82 E.

Dilution

Dilution 82 F. Expenses of the Issue 82 ITEM 10. ADDITIONAL INFORMATION 82 A. Share Capital 83 2 Table of Content s B. Constitutional Documents 83 C. Material Contracts 97 D. Exchange Controls 97 E. Taxation 97 F. Dividends and Paying Agents 104 G. 104 H. Documents on Display 104 I. Subsidiary Information 105 J. Annual Report to Security Holders 105 ITEM 11.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 105 ITEM 12.

DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES

DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES 106 A. Debt Securities 106 B. Warrants and Rights 106 C. Other Securities 106 D. American Depositary Shares 107 PART II. 109 ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES 109 ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS 109 ITEM 15.

CONTROLS AND PROCEDURES

CONTROLS AND PROCEDURES 109 ITEM 16. [RESERVED] 110 ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERT 110 ITEM 16B. CODE OF ETHICS 110 ITEM 16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES 111 ITEM 16D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES 111 ITEM 16E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS 111 ITEM 16F. CHANGE IN REGISTRANT'S CERTIFYING ACCOUNTANT 111 ITEM 16G. CORPORATE GOVERNANCE 111 ITEM 16H. MINE SAFETY DISCLOSURE 112 ITEM 16J. INSIDER TRADING POLICIES 112 ITEM 16K. CYBERSECURITY 112 PART III. 112 ITEM 17.

FINANCIAL STATEMENTS

FINANCIAL STATEMENTS 112 ITEM 18.

FINANCIAL STATEMENTS

FINANCIAL STATEMENTS 112 ITEM 19. EXHIBITS 113 3 Table of Content s GLOSSARY OF TERMS AND DEFINITIONS When the following terms and abbreviations appear in the text of this report, they have the meanings indicated below: ADSs American Depository Shares ALC Australian land corporation AMC Advanced Manufacturing Center Apollo Group Apollo Group Pty Ltd ARPA-E Advanced Research Projects Agency-Energy ARH TM IperionX proprietary technology for alkaline roasting and hydrolysis ASIC Australian Securities and Investments Commission ASTM American Society of Testing and Materials ASX Australian Securities Exchange Blacksand Blacksand Technology LLC CAA Clean Air Act CAP Compensation Advisory Partners CCO Chief Commercial Officer CEO Chief Executive Officer CERCLA Comprehensive Environmental Response, Compensation, and Liability Act CFI Conduit foreign income CFO Chief Financial Officer CO2e Carbon dioxide equivalents COO Chief Operating Officer CSO Chief Strategy Officer CWA Clean Water Act DoW Department of War DRS Direct Registration System DTC Depository Trust Company DPA Title III a provision of the Defense Production Act of 1950 that allows the President to expand the production and supply of critical materials necessary for national defense. ECL Expected credit loss EPA United States Environmental Protection Agency EPS Earnings per share ESA Endangered Species Act Exchange Act U.S. Securities Exchange Act of 1934, as amended FATA Foreign Acquisition and Takeovers Act FIP Foreign Investment Policy FIRB Foreign Investment Review Board GHGs Greenhouse gases Green Rutile TM IperionX proprietary technology for low carbon titanium mineral enrichment GSD TM IperionX proprietary technology for the granulation sintering deoxygenation process HAMR TM IperionX patented technology for hydrogen assisted metallothermic reduction HMAPL Hyperion Metals (Australia) Pty Ltd HSPT TM IperionX patented technology for hydrogen sinteri

IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS

ITEM 1 IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS Not applicable.

OFFER STATISTICS AND EXPECTED TIMETABLE

ITEM 2 OFFER STATISTICS AND EXPECTED TIMETABLE Not applicable.

KEY INFORMATION

ITEM 3 KEY INFORMATION A. [Reserved] B. Capitalization and Indebtedness Not applicable. C. Reasons for the Offer and Use of Proceeds Not applicable. 10 Table of Content s D. Risk Factors You should carefully consider the risks described below, together with all of the other information in this annual report on Form 20-F. If any of the following risks occur, our business, financial condition and results of operations could be seriously harmed, and you could lose all or part of your investment. Further, if we fail to meet the expectations of the public market in any given period, the market price of the ADSs could decline. We operate in a competitive environment that involves significant risks and uncertainties, some of which are outside of our control. If any of these risks actually occurs, our business and financial condition could suffer and the price of the ADSs could decline. Risks Related to Our Business We have a history of financial losses and expect to incur continuing losses in the near future. We incurred net losses of $35.3 million and $21.8 million for fiscal 2025 and fiscal 2024, respectively. We incurred net cash outflows from operating and investing activities of $46.1 million and $25.1 million for fiscal 2025 and fiscal 2024, respectively. We believe that we will continue to incur net losses until the recently commenced commercial scale production of titanium metals ramps up. At June 30, 2025, we had cash reserves of $54.8 million and net assets of $92.4 million. In the longer term, the successful scale-up of the Company's titanium metal p

View Full Filing

View this 20-F filing on SEC EDGAR